PULSE Life Science Advisers ApS: Financial statements 2022
CVR: 39966573
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PULSE Life Science Advisers ApS (CVR 39966573) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,146 and a net result of DKK -14,254 compared with DKK 16,980 the year before. Equity in the 2022 report amounted to DKK 37,000. The solvency ratio was 74.7%.
- Gross Profit
- DKK -13,146
- Profit/Loss
- DKK -14,254
- Equity
- DKK 37,000
- Total Assets
- DKK 49,500
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -13K | -14K | 37K | - |
| 2021 | - | 18K | 17K | 51K | - |
| 2020 | - | 824 | 774 | 34K | - |
Official annual report
Keep an eye on PULSE Life Science Advisers ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PULSE Life Science Advisers ApS has published its annual report for 2021. Gross profit came to DKK 17,743, and the net result was DKK 16,980.
About PULSE Life Science Advisers ApS
PULSE Life Science Advisers ApS was a Danish company of the type Anpartsselskab based in Brøndby Strand, founded in 2018. The company has been dissolved on 4 October 2023. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. In 2022, the company reported a gross profit of DKK -13,146 and a net result of DKK -14,254 compared with DKK 16,980 the year before. Equity in the 2022 report amounted to DKK 37,000.
